MITAPIVAT, Placebo for MITAPIVAT, MITAPIVAT, MITAPIVAT, MITAPIVAT
AG348-C-022
Phase 3 small_molecule active
Quick answer
MITAPIVAT, Placebo for MITAPIVAT, MITAPIVAT, MITAPIVAT, MITAPIVAT for Pyruvate Kinase Deficiency is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Pyruvate Kinase Deficiency
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active